African Journal of
Biochemistry Research

  • Abbreviation: Afr. J. Biochem. Res.
  • Language: English
  • ISSN: 1996-0778
  • DOI: 10.5897/AJBR
  • Start Year: 2007
  • Published Articles: 408

Full Length Research Paper

Haptoglobin polymorphism and cardiovascular risk factors in followed epileptic patients at Fann National University Hospital

Papa Madieye GUEYE
  • Papa Madieye GUEYE
  • Laboratory of Pharmaceutical Biochemistry, Faculty of Medicine, Pharmacy, University Cheikh Anta DIOP, Dakar, Senegal.
  • Google Scholar
Moustapha DJITE
  • Moustapha DJITE
  • Laboratory of Biochemistry, University Hospital Fann, Dakar, Senegal.
  • Google Scholar
El Hadji Malick NDOUR
  • El Hadji Malick NDOUR
  • Laboratory of Pharmaceutical Biochemistry, Faculty of Medicine, Pharmacy, University Cheikh Anta DIOP, Dakar, Senegal.
  • Google Scholar
Fatou GUEYE-TALL
  • Fatou GUEYE-TALL
  • Laboratory of Biochemistry, University Hospital Fann, Dakar, Senegal.
  • Google Scholar
Nene Oumou Kesso BARRY
  • Nene Oumou Kesso BARRY
  • Laboratory of Biochemistry, University Hospital Fann, Dakar, Senegal.
  • Google Scholar
Aissatou SARR
  • Aissatou SARR
  • Laboratory of Biochemistry, University Hospital Fann, Dakar, Senegal.
  • Google Scholar
Rokhaya NDIAYE DIALLO
  • Rokhaya NDIAYE DIALLO
  • Laboratory of Pharmaceutical Biochemistry, Faculty of Medicine, Pharmacy, University Cheikh Anta DIOP, Dakar, Senegal.
  • Google Scholar
Philomène LOPEZ SALL
  • Philomène LOPEZ SALL
  • Laboratory of Pharmaceutical Biochemistry, Faculty of Medicine, Pharmacy, University Cheikh Anta DIOP, Dakar, Senegal.
  • Google Scholar
Aynina CISSE
  • Aynina CISSE
  • Laboratory of Pharmaceutical Biochemistry, Faculty of Medicine, Pharmacy, University Cheikh Anta DIOP, Dakar, Senegal.
  • Google Scholar
Pape Amadou DIOP
  • Pape Amadou DIOP
  • Laboratory of Pharmaceutical Biochemistry, Faculty of Medicine, Pharmacy, University Cheikh Anta DIOP, Dakar, Senegal.
  • Google Scholar


  •  Received: 19 March 2017
  •  Accepted: 12 July 2017
  •  Published: 31 August 2017

References

Aaberg KM, Bakken IJ, Lossius MI, Lund-Søraas C, Håberg SE, Stoltenberg C, Suren P, Chin R (2016). Comorbidity and Childhood Epilepsy: A Nationwide Registry Study. Pediatrics 138(3): pii:e20160921.
Crossref

 

Al-Balaghee S, Al-Balaghee Z, Shabani A, Ghadam P, Bandehpour M, Askari Mehr A, Kazemi B (2015). Determination of haptoglobin genotype in an Iranian population with idiopathic generalized epilepsy. Rep. Biochem. Mol. Biol. 3(2):51-55.

 

Anderson GD, Temkin NR, Dikmen SS, Diaz-Arrastia R, Machamer JE, Farhrenbruch C, Miller JW, Sadrzadeh SMH (2009). Haptoglobin Phenotype and Apolipoprotein E Polymorphism: Relationship to Post-Traumatic Seizures and Neuropsychological Functioning after Traumatic Brain Injury. Epilepsy Behav. 16(3):501-506.
Crossref

 

Asleh R, Marsh S, Shilkrut M, Binah O, Guetta J, Lejbkowicz F, Enav B, Shehadeh N, Kanter Y, Lache O, Cohen O, Levy NS, Levy AP. (2003). Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ. Res. 92(11):1193-200.
Crossref

 

Attilakos A, Papakonstantinou E, Schulpis K, Voudris K, Katsarou E, Mastroyianni S, Garoufi A (2006). Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy. Epilepsy Res. 71:229-232.
Crossref

 

Bernard DR, Langlois MR, Delanghe JR, De Buyzere ML (1997). Evolution of haptoglobin concentration in serum during the early phase of acute myocardial infarction. Euro. J. Clin. Chem. Clin. Biochem. 35(2):85-88.
Crossref

 

Conti M, Morand PC, Levillain P, Lemonnier A (1991). Improved Fluorometric. Clin. Chem. 37(7):1273-1275.

 

Eiris JM, Lojo S, Del Rio MC, Novo I, Bravo M, Pavon P, Castro-Gago M (1995). Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology 45:1155-1157.
Crossref

 

Fall M, Toure K, Seck LB, Ndiaye M, Diop AG, Ndiaye MM (2015). Profil épidémiologique et prise en charge socioéconomique des patients vivant avec l'épilepsie à Dakar, Sénégal. La Tunisie Médicale. 93(2):101-103.

 

Gogishvili AV, Kavtaradze, VG, Mamaladze GT, Arutiunova MS, Takadze GSH (1985). Haptoglobin phenotype distribution in patients at high risk of developing myocardial infarct. Kardiologiia 25(2):55-58.

 

Guetta J, Strauss M, Levy NS, Fahoum L, Levy AP (2007). Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free haemoglobin. Atherosclerosis 191(1):48-53.
Crossref

 

Hamed SA, Hamed EA, Hamdy R, Nabeshima T (2007). Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res. 74:183-192.
Crossref

 

Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, Bamford JM, Markus HS (2004). Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 127:212-219.
Crossref

 

Hauser WA, Annegers JF, Kurland LT (1991). Prevalence of epilepsy in Rochester, Minnesota: 1940–1980. Epilepsia 32:429-445.
Crossref

 

Ilzecka J (1996). The biological role of haptoglobin and behaviour of this protein in different diseases, with special attention paid to brain stroke. Ann. Univ. Mariae Curie Sklodowska Med. 51:115-121.

 

Isnard J, Guenot M, Ostrowsky K, Sindou M, Mauguiere F (2000). The role of the insular cortex in temporal lobe epilepsy. Ann. Neurol. 48(4):614-623.
Crossref

 

Isojärvi JI, Pakarinen AJ, Myllylä VV (1993). Serum lipid levels during carbamazepine medication. A prospective study. Arch. Neurol. 50:590-593.
Crossref

 

Kullo IJ, Ballantyne CM (2005). Conditional risk factors for atherosclerosis. Mayo Clin. Proc. 80:219-230.
Crossref

 

Langlois MR., Delanghe JR (1996). Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42(10):1589-1600.

 

Levy AP, Hochberg I, Jablonski K, Resnick HE, Lee ET, Best L, Howard BV (2002). Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. J. Am. Coll. Cardiol. 40(11):1984-1990.
Crossref

 

Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, Skorecki K (2000). Haptoglobin phenotype and vascular complications in patients with diabetes. N. Engl. J. Med. 343:969-670.
Crossref

 

MacKellar M, Vigerust DJ (2016). Role of Haptoglobin in Health and Disease: A Focus on Diabetes. Clin. Diabetes 34:148-157.
Crossref

 

McCorry D, Chadwick D, Marson A (2004). Current drug treatment of epilepsy in adults. Lancet Neurol. 3:729-735.
Crossref

 

Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, Ricklis RM (2001). Structure-function analysis of the antioxidant properties of haptoglobin. Blood 98(13):3693-3698.
Crossref

 

Moatti N. (2003). Athérosclérose : concepts actuels. In: Delattre J, Durand G, Jardillier JC. Biochimie pathologique: 83-90. Flammarion Médecine-Sciences, Paris, 2003.

 

N'diaye S (2010). Les hallucinations dans les épilepsies partielles à propos de 31 cas Mémoire du CES de Neurologie. Université Cheikh Anta Diop, Dakar, n°331.

 

Nakhoul FM, Zoabi R, Kanter Y, Zoabi M, Skorecki K, Hochberg I, Leibu R, Miller B, Levy AP (2001). Haptoglobin phenotype and diabetic nephropathy. Diabetologia 44(5):602-604.
Crossref

 

Ngoungou EB, Quet F, Dubreuil CM, Marin B, Houinato D, Nubukpo P, Dalmay F, Millogo A, Nsengiyumva G, Kouna-Ndouongo P, Diagana M, Ratsimbazafy V, Druet-Cabanac M, Preux PM (2006). Épidémiologie de l'épilepsie en Afrique subsaharienne : une revue de la littérature. Epilepsies 18(1):25-40.

 

Nikolaos T, Stylianos G, Chryssoula N, Irini P, Christos M, Dimitrios T, Konstantinos P, Antonis T (2004). The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med. Sci. Monit. 10:MT50-MT52.

 

Osuntokun BO, Adeuja AO, Nottidge VA (1987). Prevalence of the epilepsies in Nigerian Africans: a community-based study. Epilepsia 28:272-279.
Crossref

 

Osuntokun BO, Schoenberg BS, Nottidge VA, Adeuja A, Kale O, Adeyefa A, Bademosi O, Olumide A, Oyediran ABO, Pearson CA, Bolis CL (1982). Research protocol for measuring the prevalence of neurologic disorders in developing countries, results of pilot study in Nigeria. Neuroepidemiology 1(3):143-153.
Crossref

 

Panter SS, Sadrzadeh SM, Hallaway PE, Haines J, Anderson VE, Eaton JW (1984). Hypohaptoglobinemia: a possible predisposition to epilepsy. Trans. Assoc. Am. Physicians 97:56-62.

 

Raymond S (1962). A convenient apparatus for vertical gel electrophoresis. Clin Chem. 8:455-470.

 

Rwiza HT, Kilonzo GP, Haule J (1992). Prevalence and incidence of epilepsy in Ulanga, a rural Tanzanian District: A community-based study. Epilepsia 33:1051-1056.
Crossref

 

Saccucci P, Verdecchia M, Piciullo A, Bottini N, Rizzo R, Gloria-Bottini F, Lucarelli P, Curatolo P (2004). Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism. Neurogenetics 5:245-248.
Crossref

 

Sadrzadeh SM, Saffari Y, Bozorgmehr J (2004). Haptoglobin phenotypes in epilepsy. Clin. Chem. 50:1095-1097.
Crossref

 

Schwaninger M, Ringleb P, Winter R, Kohl B, Fiehn W, Rieser PA, Walter-Sack I (1999). Elevated plasma concentrations of homocysteine in antiepileptic drug treatment. Epilepsia 40:345-350.
Crossref

 

Stocker R, Keaney JF Jr. (2004). Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84:1381-1478.
Crossref

 

Tan TY, Lu CH, Chuang HY, Lin TK, Liou CW, Chang Wn, Chuang YC (2009). Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis. Epilepsia 50(6):1579-1586.
Crossref

 

Tekle-Haimanot R, Forsgren L, Ekstedt J. (1997). Incidence of epilepsy in rural central Ethiopia. Epilepsia 38:541-546.
Crossref

 

Temple ME, Luzier AB, Kazierad DJ (2000). Homocysteine as a risk factor for atherosclerosis. Ann. Pharmacother. 34:57-65.
Crossref

 

Tseng CF, Lin CC, Huang HY, Liu HC, Mao SJ (2004). Antioxidant role of human haptoglobin. Proteomics 4:2221-2228.
Crossref

 

Tyagi N, Ovechkin AV, Lominadze D, Moshal KS, Tyagi SC (2006). Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. J. Cell. Biochem. 98:1150-1162.
Crossref

 

Yagi K (1976). A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15:212-216.
Crossref